India faces one of the world's largest burdens of type-2 diabetes, with an estimated 101 million adults affected, second only to China. At the same time, obesity and its metabolic consequences are ...

Ozempic is a brand-name glucagon-like peptide-1 (GLP-1) medication approved by the U.S. Food and Drug Administration (FDA) to manage blood sugar in individuals with type 2 diabetes. In May 2026, ...

Starting July 1, Medicare will cover three Ozempic-style weight-loss medications for $50 per month through a new temporary ...

Novo Nordisk on Tuesday announced plans to cut the list price of its popular diabetes and weight-loss drugs Ozempic and Wegovy by as much as 50% in the U.S. next year. The Danish drugmaker indicated ...

Canada is the first G7 country to approve the lower cost weight-loss drugs, which are rolling out in pharmacies this month.

Kelly Anne is a deputy editor at Forbes Advisor overseeing the development of various initiatives, including newsletters, social media, and new content verticals. Previously, she worked as a senior ...

Confused about Ozempic, Wegovy and Mounjaro? Here's what South Africans need to know about these prescription weight-loss ...

Novo Nordisk announced it will cut Wegovy and Ozempic list prices by up to 50% starting next year. (Dhiraj Singh/Bloomberg via Getty Images) Novo Nordisk on Tuesday announced plans to cut the list ...